14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $22.23 $23.98 Wednesday, 24th Apr 2024 EXEL stock ended at $23.71. This is 1.80% more than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 2.54% from a day low at $23.19 to a day high of $23.78.
90 days $20.02 $24.07
52 weeks $18.08 $24.34

Historical Exelixis prices

Date Open High Low Close Volume
Apr 24, 2024 $23.20 $23.78 $23.19 $23.71 1 466 092
Apr 23, 2024 $23.02 $23.47 $23.02 $23.29 1 865 864
Apr 22, 2024 $22.61 $23.06 $22.60 $22.87 1 496 508
Apr 19, 2024 $22.47 $22.71 $22.23 $22.52 2 177 679
Apr 18, 2024 $23.01 $23.23 $22.46 $22.49 2 494 216
Apr 17, 2024 $22.90 $23.29 $22.83 $22.87 2 722 194
Apr 16, 2024 $22.60 $23.08 $22.53 $22.82 1 633 368
Apr 15, 2024 $22.93 $23.07 $22.64 $22.70 1 699 250
Apr 12, 2024 $22.70 $23.05 $22.63 $22.81 1 909 934
Apr 11, 2024 $23.37 $23.39 $22.42 $22.65 2 298 636
Apr 10, 2024 $23.57 $23.80 $23.38 $23.68 1 451 453
Apr 09, 2024 $23.33 $23.75 $23.29 $23.72 1 236 716
Apr 08, 2024 $23.02 $23.43 $22.85 $23.35 1 562 492
Apr 05, 2024 $23.42 $23.45 $23.08 $23.14 1 785 713
Apr 04, 2024 $23.85 $23.95 $23.38 $23.49 2 022 101
Apr 03, 2024 $23.34 $23.84 $23.34 $23.69 1 706 614
Apr 02, 2024 $23.53 $23.59 $23.24 $23.34 2 273 021
Apr 01, 2024 $23.57 $23.71 $23.22 $23.68 2 017 389
Mar 28, 2024 $23.93 $23.98 $22.70 $23.73 2 048 712
Mar 27, 2024 $23.78 $23.90 $23.66 $23.86 1 544 702
Mar 26, 2024 $23.70 $23.80 $23.58 $23.61 1 878 965
Mar 25, 2024 $23.75 $23.93 $23.65 $23.70 2 009 671
Mar 22, 2024 $24.02 $24.02 $23.77 $23.78 1 838 094
Mar 21, 2024 $23.82 $24.07 $23.56 $23.92 2 644 592
Mar 20, 2024 $23.41 $23.73 $23.28 $23.71 2 205 806
Click to get the best stock tips daily for free!

About Exelixis

Exelixis Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ capsules for the treatment of patients with progressive and metastatic medullary thyroid cancer. Its CA... EXEL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT